Chi Advisors LLC Larimar Therapeutics, Inc. Transaction History
Chi Advisors LLC
- $203 Million
- Q3 2023
A detailed history of Chi Advisors LLC transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Chi Advisors LLC holds 3,414,468 shares of LRMR stock, worth $31.3 Million. This represents 6.65% of its overall portfolio holdings.
Number of Shares
3,414,468
Previous 3,414,468
-0.0%
Holding current value
$31.3 Million
Previous $10.7 Million
26.2%
% of portfolio
6.65%
Previous 4.02%
Shares
6 transactions
Others Institutions Holding LRMR
# of Institutions
122Shares Held
67.2MCall Options Held
290KPut Options Held
38.9K-
Deerfield Management Company, L.P. (Series C) New York, NY21.2MShares$195 Million3.23% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$55.5 Million0.66% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$40.2 Million0.02% of portfolio
-
Goldman Sachs Group Inc New York, NY4.33MShares$39.8 Million0.01% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.86MShares$35.4 Million11.62% of portfolio
About Larimar Therapeutics, Inc.
- Ticker LRMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,269,200
- Market Cap $397M
- Description
- Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...